Kolexia
Corradini Nadege Pédiatrie
Corradini Nadege
Pédiatrie
Centre Léon-Bérard
Lyon, France
267 Activités
2 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Rhabdomyosarcome Récidive tumorale locale Sarcome d'Ewing Neuroblastome Ostéosarcome Tumeurs osseuses Tumeurs des tissus mous Fibromatose agressive

Collaborateurs

Voir plus
Orbach Daniel
Orbach Daniel
Clcc Institut Curie, Paris, France
Minard-Colin Veronique
Minard-Colin Veronique
Gustave-Roussy, Villejuif, France
Thomassin-Defachelles Anne-Sophie
Thomassin-Defachelles Anne-Sophie
Centre Oscar-Lambret, Lille, France
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
BMS
1 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2022
SERB
1 collaboration(s)
Dernière en 2023
Schlesinger Group France
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy: A Multi-center, Open-label, Non-randomized, Phase I Dose Escalation Study of Regorafenib (BAY 73-4506) in Pediatric Subjects With Solid Malignant Tumors That Are Recurrent or Refractory to Standard Therapy
Essai Clinique (Bayer)   18 mars 2024
CAMPFIRE: Children's and Young Adult Master Protocol for Innovative Pediatric Research
Essai Clinique (Lilly)   04 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
Essai Clinique (Lilly)   27 février 2024
STARTRK-NG: A Phase 1/2, Open-Label, Dose-Escalation And Expansion Study Of Entrectinib (Rxdx-101) In Pediatrics With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Essai Clinique (Roche)   22 février 2024
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MICCHADO: Molecular and Immunological Characterisation of High Risk CHildhood Cancer At DiagnOsis, Treatment and Follow-up - Biological Evaluation in Children, Adolescents and Young Adults -
Essai Clinique (Institut Curie)   02 février 2024
CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Essai Clinique (Institut Curie)   26 janvier 2024